News & Views
-
Read More...
Product development underway to add reference doses based on International Diabetes Federation, Australia, Canada, New Zealand and UK Guidelines (September 25, 2017 -- RICHMOND, VA) On September 18, 2017, the United States Food and Drug Administration (FDA) granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists ( …
-
Read More...
IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs (September 19, 2017 -- RICHMOND, VA) The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system. The ALRT system with IDA uses the American Association of Clinical Endocrinologists (AACE) and American Diabetes …
-
Read More...
Risk Sharing Plan Means Users Will Pay for Service Only When Specific Health Measures Are Met (RICHMOND, VA, December 21, 2015) Medical practices, health insurers, self-insured employers, and other potential users of the ALRT diabetes management system can now choose a pricing plan linked to declines in a patient’s A1C level. The plan is designed to eliminate performance risk and to provide rewards for achieving measurable health goals. “Payers are frustrated with expensive diabetes …
-
Read More...
Program Yields Significant Improvement in Glycemic Control for Clinics’ Most Challenging Patients (RICHMOND, VA, November 17, 2015) A 10-month pilot of the ALRT remote monitoring system for diabetes by the Kansas City Metropolitan Physician Association (KCMPA) has found significant improvement in glycemic control for those patients who used the system compared to those who dropped out of the pilot. Patients participating in the pilot program of the ALRT system experienced an average A1C …
-
Read More...
ALRT’s Algorithm Helps Physicians Optimize Treatment And Avoid Complications (February 17, 2015 -- RICHMOND, VA) ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce the submission of a 510(k) application to the U.S. Food and Drug Administration (FDA) for an innovative new addition to the Health-e-Connect system that will help busy physicians avoid common insulin dosing errors and remotely manage large populations of …
-
Read More...
Richmond Bizsense – April 29, 2015 A local technology company has landed its first paid client since making a strategic shift toward disease monitoring systems two years ago. ALR Technologies, which offers a platform to remotely monitor diabetes patients, has signed a contract with Clay Platte Family Medicine Clinic. The deal will give ALRT and its Internet-based Health-e-Connect system access to the Kansas City, Missouri, primary care clinic’s 3,400 diabetes patients. Data uploaded …
-
Read More...
Health-e-Connect System Deployed to Improve Diabetes Outcomes at Leading Kansas City Medical Group (April 20, 2015 -- RICHMOND, VA) ALR Technologies Inc. (OTCQB: ALRT), a leading remote chronic care management and medical device company, is pleased to announce that Clay-Platte Family Medicine Clinic, one of the largest primary care clinics in the Northland of Kansas City, has signed a contract with ALRT to improve diabetes health outcomes using the Health-e-Connect remote chronic care …
-
Read More...
Outcomes Study with Hospital Clinico Metropolitano La Florida will test the efficacy of remote monitoring and remote insulin adjustments; Nipro to provide their latest FDA-cleared glucose meters, diagnostic supplies and enrollment support RICHMOND, Va., Jan. 20, 2015 - ALR Technologies Inc. (ALRT) announced that Nipro Diagnostics, Inc. and Nipro Medical Corporation have agreed to participate in a clinical outcomes study to be conducted by ALRT and Hospital Clinico Metropolitano La Florida, one …
-
Read More...
Los estudios de los resultados con el Hospital Clínico Metropolitano La Florida, pondrá a prueba la eficacia de la vigilancia remota y los ajustes de dosis de insulina; Nipro proporcionara Glucómetros de alta tecnología aprobados por la FDA, equipos de diagnóstico y apoyo para la inscripción. Richmond, VA, 20 de Enero 2015 - ALR Technologies Inc. (OTCQB: ALRT) anunciaron que Nipro Diagnostics, Inc. y Nipro Medical Corporation han acordado participar en un estudio clínico que será realizado por …
-
Read More...
Health-e-Connect Helps Care Providers Secure Significant New Revenue Stream (January 7, 2015 -- RICHMOND, VA) Medical practices may be able to secure new revenue while they improve outcomes for patients with diabetes by using Health-e-Connect, the remote diabetes care management system from ALR Technologies Inc. (OTCQB: ALRT). An analysis from Avalere Health LLC, commissioned by ALRT, follows the Centers for Medicare & Medicaid Services’ (CMS) establishment of a new reimbursement code …
News: Yes